top of page

Israeli team develops 'anti-diabetes drug'

463 million people have been diagnosed with diabetes worldwide

and up to 95% of this number have Type 2.

Israeli team develops 'anti-diabetes drug'


Logo concenter biopharma.jpg

Hi, thanks for stopping by!

Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., which developed a novel, protected PLATFORM of drugs for proven treatments of multiple indications. 


Our PLATFORM is the result of extensive investigation of animal models of human diseases.

Let the news
come to you.

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
bottom of page